awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38795712-A4B72293-07F1-4112-B5E9-D3DC24FE5B05
Q38795712-A4B72293-07F1-4112-B5E9-D3DC24FE5B05
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38795712-A4B72293-07F1-4112-B5E9-D3DC24FE5B05
PARP inhibitors as antitumor agents: a patent update (2013-2015).
P2860
Q38795712-A4B72293-07F1-4112-B5E9-D3DC24FE5B05
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38795712-A4B72293-07F1-4112-B5E9-D3DC24FE5B05
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d595f71da5d2e047a49d1a5a8dd6e6a0596524f
P2860
Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status.